Patents by Inventor Camille AMALRIC

Camille AMALRIC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220089609
    Abstract: The present invention relates to novel quinazolinone derivatives of formula (I) as well as pharmaceutical compositions containing these compounds. The compounds of formula (I) as provided herein can act as positive allosteric modulators of metabotropic glutamate receptor subtype 4 (mGluR4), and can thus be used as therapeutic agents, particularly in the treatment or prevention of conditions associated with altered glutamatergic signalling and/or functions or conditions which can be affected by alteration of glutamate level or signalling.
    Type: Application
    Filed: July 26, 2019
    Publication date: March 24, 2022
    Applicant: DOMAIN THERAPEUTICS
    Inventors: Camille AMALRIC, Anaïs BARRE, Stephan SCHANN, Stanislas MAYER, Ismet DORANGE, Baptiste MANTEAU, Anne-Laure BLAYO
  • Publication number: 20210361669
    Abstract: The present invention relates to novel 5-azaindazole derivatives of formula (I), as described and defined herein, and pharmaceutically acceptable salts, solvates and prodrug thereof, as well as pharmaceutical compositions comprising such compounds. The 5-azaindazole derivatives according to the invention have been found to be highly effective dual A2A/A2B adenosine receptor antagonists, and can thus be used as therapeutic agents, particularly in the treatment or prevention of hyperproliferative or infectious diseases or disorders.
    Type: Application
    Filed: October 22, 2019
    Publication date: November 25, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Anne-Laure BLAYO, Bapriste MANTEAU, Camille AMALRIC, Stanislas MAYER, Stehan SCHANN, Mickaël FER